Actively Recruiting
Inflammation in Vascular Disease
Led by Göteborg University · Updated on 2025-05-06
170
Participants Needed
1
Research Sites
387 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Increasing evidence suggests that systemic low-grade inflammation may be a driving force of cardiometabolic complications, such as vascular dysfunction, atherosclerosis and ischemic heart disease. Thus, we will investigate the role of inflammation in cardiovascular disease.
CONDITIONS
Official Title
Inflammation in Vascular Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient is planned to undergo vascular surgery.
- Signed informed consent has been obtained from the patient.
You will not qualify if you...
- Patient has difficulty to understand information.
- Patients under 18 years of age.
- Patients participating in any drug-related study.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Gothenburg
Gothenburg, Vastragotaland, Sweden, 40530
Actively Recruiting
Research Team
E
Emma Borgeson, PhD
CONTACT
P
Per Skoog, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here